Callisto Pharmaceuticals (KAL) Files Suit Against Former Executive Vice President, R&D
More News related to KAL
- Callisto (KAL) Receives Delisting Notification From AMEX; Receives 'Going Concern' From Auditor
- Callisto Pharmaceuticals (KAL) Receives Non-Compliance Notification From AMEX
- Callisto Pharmaceuticals (KAL) Files Suit Against Former Executive Vice President, R&D
- Rodman and Renshaw Starts Callisto Pharmaceuticals (KAL) at Outperform
- Callisto Pharmaceuticals (KAL) Opens L-Annamycin Phase I Clinical Trial in Pediatric Relapsed or Refractory Acute Leukemia
More News related to TPPH
- Tapestry Pharmaceuticals (TPPH) Shares To Be Delisted; Company May File Bankruptcy
- Tapestry Pharmaceuticals (TPPH) Withdrawals Proposed $40 Million Stock Offering
- Callisto Pharmaceuticals (KAL) Files Suit Against Former Executive Vice President, R&D
- TPPH Gets Nasdaq Compliance Notice
More News related to Corporate News
- S&P Announces Change to US Index: TSRA for FIF
- RealNetworks (RNWK) and MTV Networks (VIA-B) to Split Off Joint Venture Rhapsody
- Watts Water (WTS) Board Approves Restructuring Program; Shutting Down 3 Plants, Cutting 95 Jobs
- Transcept Pharmaceuticals (TSPT) Granted U.S. Patent Covering Intermezzo Formulation
- AAR (AIR) Predicts Impact of Mesa's Bankruptcy on Q3 Results
Callisto Pharmaceuticals, Inc. (Amex: KAL) has filed a complaint against Donald Picker, its former Executive Vice President, Research & Development in the Supreme Court of the State of New York alleging that (i) Dr. Picker breached his written employment agreement with Callisto by accepting employment with Tapestry Pharmaceuticals, Inc. (Nasdaq: TPPH) in a manner not in accordance with his agreement, (ii) Dr. Picker acted fraudulently by failing to reveal to Callisto that he was negotiating employment with Tapestry while purportedly representing Callisto in negotiations with Tapestry pursuant to a confidential disclosure agreement between Tapestry and Callisto and (iii) Dr. Picker misappropriated confidential files and materials from Callisto's offices. Callisto is seeking $80 million in damages from Dr. Picker.
Related Categories
Corporate NewsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
